MIT Report: IBM Watson, machine-learning plays "overhyped"
IBM (NYSE:IBM) Watson Health, and other machine-learning company's immediate impact on healthcare may have been significantly overhyped, promoting a timeline that it may not be able to reach, according to a new article from MIT's Technology Review. The fault lies not with the company, however, but the complexity and relative unavailability of data that it and [...]
No comments:
Post a Comment